MedTrace Logo

Cosmetic Results With Tissue Adhesive vs. Subdermal Sutures in Cesarean Section

NCT06760026 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-02-17

No results posted yet for this study

Summary

Morbidity associated with post-cesarean wound closure, including cosmetically unfavorable scarring, is a significant concern in obstetrics, impacting patient satisfaction and recovery. Recent advances have introduced the use of tissue adhesives, such as 2-octylcyanoacrylate, which promise to improve cosmetic outcomes and reduce postoperative complications. This study will evaluate different tissue adhesive application schedules, keeping the total dose constant, to determine whether the method of application influences cosmetic results and the incidence of postoperative complications

Conditions

  • Cesarean Wound Repair
  • Cesarean Section Scar
  • Cosmetic Appearance of Cesarean Scar
  • Tissue Adhesives

Interventions

PROCEDURE

2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision

2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision

PROCEDURE

subdermal suture

wound closure with subdermal sutures using 2-0 nylon thread, under the same evaluation scheme

Sponsors & Collaborators

  • Ricardo A Gutierrez Ramirez, MD, MSc, FACOG

    lead OTHER

Principal Investigators

  • Ricardo A. Gutierrez Ramirez, MD, MSc · Universidad Nacional Autonoma de Honduras

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-07-31
Completion
2025-12-30

Countries

  • Honduras

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06760026 on ClinicalTrials.gov